Copyright
©2013 Baishideng Publishing Group Co.
World J Gastroenterol. Feb 28, 2013; 19(8): 1210-1218
Published online Feb 28, 2013. doi: 10.3748/wjg.v19.i8.1210
Published online Feb 28, 2013. doi: 10.3748/wjg.v19.i8.1210
Figure 7 Effects of mitogen-activated protein kinases inhibitors on (±)-S-nitroso-N-acetylpenicillamine-induced action in interstitial cells of Cajal.
A: Pacemaker currents of interstitial cells of Cajal (ICCs) treated with 100 μmol/L SNAP at a holding potential of -70 mV; B: Pacemaker currents after pretreatment with PD 98059 (10 μmol/L) prior to SNAP treatment; C: Pacemaker currents after pretreatment with SB 203580 (10 μmol/L) prior to SNAP treatment; D: Pacemaker currents after pretreatment with L-NAME (10 μmol/L) prior to prostaglandin E2 (PGE2) (5 μmol/L) treatment. The effects of mitogen-activated protein kinases inhibitors on the (±)-S-nitroso-N-acetylpenicillamine-induced action are summarized in E and F. Bars represent mean ± SE values (n = 5 per group). Con: Control, PD: PD 98059, SB: SB203580; SNAP: S-nitroso-N-acetylpenicillamine; L-NAME: NG-Nitro-L-arginine Methyl Ester.
-
Citation: Zuo DC, Choi S, Shahi PK, Kim MY, Park CG, Kim YD, Lee J, Chang IY, So I, Jun JY. Inhibition of pacemaker activity in interstitial cells of Cajal by LPS
via NF-κB and MAP kinase. World J Gastroenterol 2013; 19(8): 1210-1218 - URL: https://www.wjgnet.com/1007-9327/full/v19/i8/1210.htm
- DOI: https://dx.doi.org/10.3748/wjg.v19.i8.1210